The findings of a medical study published in The Lancet on Monday revealed that a 62-year-old German citizen has had 217 jabs of vaccines against SARS-CoV-2, the virus that causes coronavirus disease (COVID-19).

The sexagenarian, identified only as the Hypervaccinated Individual from Magdeburg, Germany, disregarded medical advice and received 217 vaccinations within 29 months aiming to fortify his immune system against the viral disease, the report stated.

The researchers disclosed that they became aware of HIM’s unique case of “hypervaccination” when German authorities, upon initially discovering that he had received 130 vaccination doses in a nine-month period, began a fraud investigation to determine whether he had broken any laws.

“We learned about his case via newspaper articles,” Kilian Schober, one of the researchers, said in a statement. “We then contacted him and invited him to undergo various tests. He was very interested in doing so.”

HIM availed his blood samples including frozen ones taken over a period of years for the study.

The Lancet researchers could not detect any side effects and “abnormalities” in HIM “attributable to hypervaccination” even though they initially thought the excessive vaccines might weaken his immune cells.

“Our case report shows that SARS-CoV-2 hypervaccination did not lead to adverse events,” the study stressed.

Katharina Kocher, a lead author of the study, said they “did not find any indication for a weaker immune response, rather the contrary.

They found that the patient had never contracted the virus but could not determine whether or not the numerous jabs played a role in it.

“While we found no signs of SARS-CoV-2 breakthrough infections in HIM to date, it cannot be clarified whether this is causally related to the hypervaccination regimen,” The Lancet stated in their study.

Still, they concluded that they would not recommend hypervaccination as a protective measure to strengthen one’s immunity.

“Importantly, we do not endorse hypervaccination as a strategy to enhance adaptive immunity.”